A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease

NCT01448850 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

464

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

BIOLOGICAL: MEDI8968 600 mg IV, 300 mg SC
OTHER: Placebo

Sponsor

MedImmune LLC